Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Doctor Sacks has served as a member of our Board of Directors since August 2017.
Dex joined Zymeworks in September 2017, and currently serves as our Vice President, Legal and Corporate Secretary.
Doctor Sacks is a trained oncologist, and has served as the Chief Medical Officer of Harpoon Therapeutics, Inc. since October 2018.
Doctor Josephson joined Zymeworks in April 2019 and currently serves as our Chief Medical Officer.
Cox has served as a member of our Board of Directors since June 2019.
Doctor Neu has served as a member of our Board of Directors since March 2020.
Doctor Wilde has served as VP of Clinical Operations since March 2021.
Doctor Astle joined Zymeworks in April 2021 and currently serves as Senior Vice President and Chief Financial Officer.
Galbraith has served as Zymeworks’ Chair & CEO since January 2022.
Doctor Mangeshkar joined Zymeworks in January 2022 as Vice President, Biometrics.
Rate how well Zymeworks lives up to its initial vision.
Do you work at Zymeworks?
Is Zymeworks' vision a big part of strategic planning?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Moderna | 2010 | $3.2B | 2,500 | 83 |
| Emergent BioSolutions | 1998 | $1.6B | 1,834 | 11 |
| Human Genome Sciences | 1992 | $131.0M | 1,000 | - |
| Spectrum Pharmaceuticals | 2002 | $10.1M | 235 | - |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 692 |
| Merck | 1891 | $64.2B | 74,000 | 2,272 |
| Cubist Pharmaceuticals | 1992 | $926.4M | 873 | - |
| Vertex Pharmaceuticals | 1989 | $11.0B | 3,400 | 121 |
| Quidel | 1979 | $1.7B | 1,500 | - |
| MacroGenics | 2000 | $150.0M | 307 | 11 |
Zippia gives an in-depth look into the details of Zymeworks, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Zymeworks. The employee data is based on information from people who have self-reported their past or current employments at Zymeworks. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Zymeworks. The data presented on this page does not represent the view of Zymeworks and its employees or that of Zippia.
Zymeworks may also be known as or be related to ZYMEWORKS INC., Zymeworks, Zymeworks Biopharmaceuticals Inc., Zymeworks Inc, Zymeworks Inc. and Zymeworks, Inc.